Variant report
Variant | nsv968811 |
---|---|
Chromosome Location | chr5:8326997-8327932 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:8326714..8328797-chr5:8452465..8455003,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146241828 | chr5:8327013-8327014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138361209 | chr5:8327017-8327018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535478427 | chr5:8327027-8327028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115792632 | chr5:8327053-8327054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141871081 | chr5:8327091-8327092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537522143 | chr5:8327092-8327093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7717975 | chr5:8327096-8327097 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs150615930 | chr5:8327103-8327104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539998446 | chr5:8327136-8327137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76470325 | chr5:8327164-8327165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570160066 | chr5:8327174-8327175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369517321 | chr5:8327203-8327204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561919710 | chr5:8327218-8327219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113831594 | chr5:8327228-8327229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559618142 | chr5:8327300-8327301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78352549 | chr5:8327303-8327304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529902322 | chr5:8327326-8327327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564539480 | chr5:8327336-8327337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533577146 | chr5:8327398-8327399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547210063 | chr5:8327446-8327447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567210465 | chr5:8327465-8327466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377657455 | chr5:8327473-8327474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548989532 | chr5:8327500-8327501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185726963 | chr5:8327505-8327506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149856222 | chr5:8327507-8327508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537813351 | chr5:8327549-8327550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569876111 | chr5:8327563-8327564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190252576 | chr5:8327564-8327565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577273053 | chr5:8327568-8327569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533785389 | chr5:8327584-8327585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147545471 | chr5:8327635-8327636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76785197 | chr5:8327666-8327667 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542537914 | chr5:8327670-8327671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs180952136 | chr5:8327701-8327702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140170509 | chr5:8327779-8327780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10475424 | chr5:8327822-8327823 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs538795179 | chr5:8327860-8327861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145608930 | chr5:8327904-8327905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565801088 | chr5:8327908-8327909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:8326800-8330200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr5:8327000-8327600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr5:8327000-8328200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr5:8327200-8327600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr5:8327200-8328200 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr5:8327600-8328000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr5:8327800-8328000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:8327800-8328200 | Enhancers | Primary hematopoietic stem cells | blood |